• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Evaluating the impact of age on immune checkpoint therapy biomarkers.

作者信息

Erbe Rossin, Wang Zheyu, Wu Sharon, Xiu Joanne, Zaidi Neeha, La Jennifer, Tuck David, Fillmore Nathanael, Giraldo Nicolas A, Topper Michael, Baylin Stephen, Lippman Marc, Isaacs Claudine, Basho Reva, Serebriiskii Ilya, Lenz Heinz-Josef, Astsaturov Igor, Marshall John, Taverna Josephine, Lee Jerry, Jaffee Elizabeth M, Roussos Torres Evanthia T, Weeraratna Ashani, Easwaran Hariharan, Fertig Elana J

出版信息

Cell Rep. 2021 Nov 16;37(7):110033. doi: 10.1016/j.celrep.2021.110033.

DOI:10.1016/j.celrep.2021.110033
PMID:34788629
Abstract
摘要

相似文献

1
Evaluating the impact of age on immune checkpoint therapy biomarkers.评估年龄对免疫检查点治疗生物标志物的影响。
Cell Rep. 2021 Nov 16;37(7):110033. doi: 10.1016/j.celrep.2021.110033.
2
Myeloid Cells as Clinical Biomarkers for Immune Checkpoint Blockade.髓系细胞作为免疫检查点阻断的临床生物标志物。
Front Immunol. 2020 Jul 24;11:1590. doi: 10.3389/fimmu.2020.01590. eCollection 2020.
3
Evaluating the impact of age on immune checkpoint therapy biomarkers.评估年龄对免疫检查点治疗生物标志物的影响。
Cell Rep. 2021 Aug 24;36(8):109599. doi: 10.1016/j.celrep.2021.109599.
4
Biomarkers of immune checkpoint inhibitor response and toxicity: Challenges and opportunities.免疫检查点抑制剂反应和毒性的生物标志物：挑战与机遇。
Immunol Rev. 2023 Sep;318(1):157-166. doi: 10.1111/imr.13249. Epub 2023 Jul 20.
5
Immune checkpoint inhibitors in GBM.胶质母细胞瘤中的免疫检查点抑制剂
J Neurooncol. 2021 Oct;155(1):1-11. doi: 10.1007/s11060-021-03859-8. Epub 2021 Oct 1.
6
Biomarkers for evaluating the clinical response to immune checkpoint inhibitors in renal cell carcinoma (Review).评估免疫检查点抑制剂在肾细胞癌中的临床应答的生物标志物（综述）。
Oncol Rep. 2024 Dec;52(6). doi: 10.3892/or.2024.8823. Epub 2024 Oct 18.
7
Predictive Biomarkers for Checkpoint Blockade in Urothelial Cancer: A Systematic Review.预测性生物标志物在尿路上皮癌中的免疫检查点阻断：系统评价。
J Urol. 2019 Jul;202(1):49-56. doi: 10.1097/JU.0000000000000136. Epub 2019 Jun 7.
8
[Biomarkers for Neoadjuvant Immune Checkpoint Inhibitors 
in Non-small Cell Lung Cancer].[非小细胞肺癌新辅助免疫检查点抑制剂的生物标志物]
Zhongguo Fei Ai Za Zhi. 2022 Feb 20;25(2):130-136. doi: 10.3779/j.issn.1009-3419.2022.102.04.
9
The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer.卵巢癌免疫检查点阻断治疗的预测和预后生物标志物的现状。
Front Immunol. 2022 Oct 27;13:1045957. doi: 10.3389/fimmu.2022.1045957. eCollection 2022.
10
Immune checkpoint inhibitors in advanced non-small cell lung cancer.免疫检查点抑制剂在晚期非小细胞肺癌中的应用。
Cancer. 2018 Jan 15;124(2):248-261. doi: 10.1002/cncr.31105. Epub 2017 Dec 6.

引用本文的文献

1
Effects of aging on anticancer therapy in murine cancer models.衰老对小鼠癌症模型中抗癌治疗的影响。
Cancer Metastasis Rev. 2025 Aug 29;44(3):66. doi: 10.1007/s10555-025-10282-2.
2
Cancer progression through the lens of age-induced metabolic reprogramming.从年龄诱导的代谢重编程角度看癌症进展
Nat Rev Cancer. 2025 Jul 11. doi: 10.1038/s41568-025-00845-4.
3
Integrative Analysis of Bulk Multiomics and Single-Cell Transcriptomics Elucidates Age-Related Molecular Landscape Alterations in Cervical Cancer.批量多组学与单细胞转录组学的综合分析揭示了宫颈癌中与年龄相关的分子景观改变。
Ann Surg Oncol. 2025 May 26. doi: 10.1245/s10434-025-17464-w.
4
Pembrolizumab in gestational trophoblastic neoplasia: Systematic review and meta-analysis with sub-group analysis of potential prognostic factors.帕博利珠单抗治疗妊娠滋养细胞肿瘤：系统评价与荟萃分析及潜在预后因素的亚组分析
Clinics (Sao Paulo). 2025 Mar 2;80:100583. doi: 10.1016/j.clinsp.2025.100583. eCollection 2025.
5
Tumor Microenvironment Drives the Cross-Talk Between Co-Stimulatory and Inhibitory Molecules in Tumor-Infiltrating Lymphocytes: Implications for Optimizing Immunotherapy Outcomes.肿瘤微环境驱动肿瘤浸润淋巴细胞中共刺激分子与抑制分子之间的相互作用：对优化免疫治疗结果的启示。
Int J Mol Sci. 2024 Nov 29;25(23):12848. doi: 10.3390/ijms252312848.
6
Age-Associated Contraction of Tumor-Specific T Cells Impairs Antitumor Immunity.年龄相关的肿瘤特异性 T 细胞收缩损害抗肿瘤免疫。
Cancer Immunol Res. 2024 Nov 4;12(11):1525-1541. doi: 10.1158/2326-6066.CIR-24-0463.
7
Machine learning models based on fluid immunoproteins that predict non-AIDS adverse events in people with HIV.基于体液免疫蛋白的机器学习模型可预测艾滋病毒感染者的非艾滋病不良事件。
iScience. 2024 May 8;27(6):109945. doi: 10.1016/j.isci.2024.109945. eCollection 2024 Jun 21.
8
Unique characteristics of the tumor immune microenvironment in young patients with metastatic colorectal cancer.年轻转移性结直肠癌患者肿瘤免疫微环境的独特特征。
Front Immunol. 2023 Dec 13;14:1289402. doi: 10.3389/fimmu.2023.1289402. eCollection 2023.
9
Considerations and Approaches for Cancer Immunotherapy in the Aging Host.衰老宿主中的癌症免疫治疗的考虑因素和方法。
Cancer Immunol Res. 2023 Nov 1;11(11):1449-1461. doi: 10.1158/2326-6066.CIR-23-0121.
10
Mechanisms driving the immunoregulatory function of cancer cells.驱动癌细胞免疫调节功能的机制。
Nat Rev Cancer. 2023 Apr;23(4):193-215. doi: 10.1038/s41568-022-00544-4. Epub 2023 Jan 30.